Skip to main content
Premium Trial:

Request an Annual Quote

Adaptive Biotechnologies: Mark Adams, Jyoti Palaniappan, Thomas Snyder

Adaptive Biotechnologies has appointed Mark Adams as chief technical officer, Jyoti Palaniappan as senior vice president of clinical diagnostics for the ImmunoSeq Dx program, and Thomas Snyder as vice president of research, ImmunoSeq Dx.

Adams has been involved in the strategy, design, and implementation of large-scale bioinformatics and data analytics programs for companies including SVB Leerink, Celmatix, Good Start Genetics, and Variagenics. He holds a PhD in cell biology from Baylor College of Medicine and completed his postdoc in computational biology at Boston University. He assumes the CTO role from Sean Nolan, who will fill a newly created role of distinguished engineer.

Palaniappan previously served as chief commercial officer for Bigfoot Biomedical. He also spent 11 years in Abbott's diabetes care business. Prior to Abbott he led global and US commercial organizations for Thermo Fisher Scientific, and provided strategic consulting services at McKinsey & Company. He holds an MBA/MPH from Emory University.

Snyder returns to Adaptive after five years as head of computational biology at Verily (formerly Google Life Sciences).

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.